HemoTypeSC Has a CE Mark and is Registered in Ghana, Nigeria, and Kenya

Pre-Release Press Conference to Discuss Uganda Validation Study Data

Erik Serrao, PhD, of Silver Lake Research Corporation, Azusa, CA, presents the implementation of a sickle cell disease screening program in Uganda using HemoTypeSC. Newborn diagnostic screening is not widely implemented in Africa due to cost and logistical problems with current diagnostic methods; a low-cost, user-friendly test is needed to help address this issue.
 
VJHemOnc – Video Journal of Hematological Oncology
ASH Conference 2018